With the state of Kentucky about to implement the medical marijuana program in 2025, a number of patients and carers are optimistic that cannabis-based medicine will restore life-changing conditions. Neurological, gastrointestinal and psychiatric diseases are also chronic, and conventional therapies cannot be effective in management. With the emergence of a controlled medical marijuana program, there is now a ray of hope, particularly to people with epilepsy or other immune seizure conditions, multiple sclerosis, muscle spasms, spasticity, chronic nausea, cyclical vomiting syndrome, and PTSD (post-traumatic stress disorder). The law regarding medical marijuana in Kentucky incorporated in Senate Bill 47 permits qualified patients to use non-smokeable cannabis, meaning oils, tinctures, edibles, and capsules.